###  [:house:返回首頁](https://github.com/ourhimalayas/txt)
---

## 【世事解评】闫博士第三篇报告部分内容翻译及浅释（续三）
` 纽约香草山MOS01` [轉載自GNews](https://gnews.org/zh-hans/1123364/)

作者：纽约香草山农场  霍比特人



![]()![](https://gnews.org/wp-content/uploads/2021/01/GNEW-GTV-MOS-LOGO-2-2-1.jpg)



本文继续摘取并翻译闫博士第三篇报告中点对点回应约翰·霍普金斯健康保障中心的评议，并根据自身理解稍作解释。
![]()![](https://media.discordapp.net/attachments/721544615953432698/831671306470293534/image0.jpg?width=1083&amp;height=609)

> 2. **Role of Chinese military lab. **Lines 4-6: The United States has a number of high-containment laboratories in which viruses can be studied safely with engineering controls, including negative air pressure. Some of these labs are located at military laboratories, such as the US Army Medical Research Institute of Infectious Diseases in Frederick, Maryland. China, France, Germany, India, Russia, the United Kingdom, and many other countries similarly have laboratories operated by military researchers that are declared to the Biological Weapons Convention in confidence-building measures. Scientific investigation in military laboratories is not uncommon; coronavirus research performed in a Chinese military research institute is not in itself suspicious, as asserted by Yan et al.


【评议者】

中（共）国军方实验室的角色。第4-6行，美国有一些高防护等级实验室，使得病毒可以安全地在工程控制下（包括空气负压）在其中被研究。这类实验室有一些也位于地方军队实验室中，例如在马里兰州弗雷德里克的美国传染病的军队医学研究所。在生物武器条约的可信任机制之下，中（共）国、法国、德国、印度、俄国、英国，以及许多其他国家都存在由军方研究员运作的实验室。在军事实验室做科学研究并不稀奇。在中（共）国军事研究机构进行的冠状病毒研究自身并不如闫等人所说的那样可疑。


> Response: Warmbrod et al. once again distorted the meaning of our report. Our exact words here were:
> 
> “*The genomic sequence of SARS-CoV-2 is suspiciously similar to that of a bat coronavirus discovered by military laboratories in the Third Military Medical University (Chongqing, China) and the Research Institute for Medicine of Nanjing Command (Nanjing, China)*.”
> 
> Clearly, what we have referred to as suspicious was the sequence similarity between SARS-CoV-2 and ZC45/ZXC21. Not at all should our writing be interpreted as all scientific investigations in military laboratories are suspicious. Like in other places, Warmbrod et al. intentionally distorted our meaning to create a room, which is otherwise non-existent, to insert their criticisms.
> 
> With that said, we do believe that the CCP military played a role both in the creation of SARS-CoV-2 and in the cover-up after it is unleashed into the human population. As shown in our second report, the fabrications of pangolin coronaviruses involved the *Academy of Military Medical Sciences*(AMMS) in multiple accounts. These fabrications were used as cover-ups to mislead the world into believing that SARS-CoV-2 has a natural origin. The extensive cover-up involving Chinese military research groups is extremely evident. Could Warmbrod et al. offer examples of large-scale, government-organized fabrications of viruses that were used to cover up the origin of SARS-CoV-2 or any other viral pathogen? Or could Warmbrod et al. provide evidence to prove that the pangolin coronaviruses published by the Chinese military research groups are not fraudulent? Without these, they have no basis to deny the involvement of the CCP military scientists in the creation and cover-up of SARS-CoV-2.


【闫博士】回应：

沃姆布罗德等人再一次歪曲了我们的报告。我们的原话如下：

*新冠的基因序列可疑地与第三军医大学（中国重庆）和南京军区医学研究所（中国南京）的军事实验室发现的蝙蝠冠状病毒序列相似。*

很明显，我们认为可疑的是新冠与ZC45/ZXC21序列之间的相似性。我们的报告根本不应该被理解为军事实验室的科学研究都是可疑的。如其他地方一样，沃姆布罗德等人故意歪曲我们的意思，来创造压根儿不存在的空间来塞入他们的批评。

如上所述，我们确实相信中共军方实验室在制造新冠和在它流入人群后的掩盖中扮演了某种角色。如我们第二篇报告所述，军事医学科学院（AMMS）以多个理由卷入了穿山甲冠状病毒的伪造。这些伪造被用于掩盖真相、误导世界，令世界相信新冠有某种自然的起源。中（共）国军方研究团队参与了这一广泛掩盖事实的做法，这是极端明显的。沃姆布罗德等人能举出如此大范围的政府组织参与的病毒造假案例，用于掩盖新冠或任何其他病原病毒的起源吗？沃姆布罗德等人能提供证据证明中共军方研究团队发表的穿山甲冠状病毒不是伪造的？如果没有，他们就没有根据来否认中共军方科学家参与了制造和掩盖新冠这一事实。


> 3. Furin cleavage sites in coronaviruses. Lines 10-16: The authors assert that a furin cleavage site in its Spike protein is absent in coronaviruses found in nature, which is not the case. SARS-CoV-1 and the Middle East respiratory syndrome (MERS) have furin cleavage sites in their Spike protein. This is fairly common in other coronaviruses; MERS has a furin cleavage site within Spike.


【评议者】

冠状病毒中的弗林酶切位点。第10-16行，作者断言在它（新冠）的刺突蛋白里一个弗林酶切位点是自然界发现的冠状病毒里没有的。但事情并非如此。SARS1和中东呼吸综合症（MERS）都在刺突里有弗林酶切位点。这在其他冠状病毒里也很常见。MERS在刺突里就有一个弗林酶切位点。


> Response: Warmbrod once again distorted our report here to then launch their otherwise unjustified criticism. We have clearly stated that, except for SARS-CoV-2, no lineage B β coronaviruses have a furin-cleavage site at the S1/S2 junction. Yet, Warmbrod et al. distorted our description and omitted “lineage B β” and “at the S1/S2 junction” here in their criticisms. Such intentional distortion of our report has shown up repeatedly in their comments, which not only proves the biased nature of their review but also puts their motives in question.
> 
> Furthermore, SARS-CoV-1 does not have a furin-cleavage site at the S1/S2 region. It has a furin-cleavage site at the S2′. For MERS, there is a furin-cleavage site at the S1/S2 junction. However, MERS does not belong to the lineage B of β coronaviruses. Therefore, our original description – “*(w)ithin the lineage B of β coronaviruses and with the exception of SARS-CoV-2, no viruses contain a furin-cleavage site at the S1/S2 junction*” – was accurate and factual.


【闫博士】回应：

沃姆布罗德等人又在歪曲我们的报告来散布他们根本是不公正的批评。我们已经清楚地说过，除了新冠之外，没有B系β冠状病毒在S1/S2联接部有弗林酶切位点。然而，沃姆布罗德等人歪曲我们的叙述而在他们的批评中省略了“B系β”和“S1/S2联接部”。这种故意的对我们报告的歪曲在其评议中反复出现，这不仅证明他们的评议的偏见本质，也证明他们的动机是可疑的。

更进一步的是，SARS1在S1/S2联接部没有弗林酶切位点，它在S2有。至于MERS，它在S1/S2联接部有一个，然而MERS不属于B系β冠状病毒。所以，我们的原始叙述是精确且真实的。


> 4. **Dissimilarities between SARS-CoV-2 and ZC45. **Figure 1.1: The report features a figure comparing sequences of various coronavirus strains. The figure’s data appear accurate and demonstrate a high degree of dissimilarity between ZC45 and SARS-CoV-2, particularly in ORF1a, but the conclusion made by the authors in the text is that the strains are similar. Neither the figure nor the text clarifies which genome serves as the reference.


【评议者】

新冠和ZC45的差异性。图1.1，报告画了一张图表描述各种不同的冠状病毒菌株的序列比较。这图表的数据似乎很精确，但也显示出ZC45和新冠的高度差异性，尤其是Orf1a。但是，作者的结论文字却表示，这些菌株是相似的。图表和文字都不能表明基因组是如引证所述的那样。


> Response: Warmbrod et al. used this same trick here again to fool their readers – they distort our true description. Our exact description here on the similarity between ZC45 and SARS-CoV-2 was:
> 
> “*Searching the NCBI sequence database reveals that, among all known coronaviruses, there were two related bat coronaviruses, ZC45 and ZXC21, that share the highest sequence identity with SARS-CoV-2 (each bat coronavirus is ~89% identical to SARS-CoV-2 on the nucleotide level)*.”
> 
> Our description here is true and accurate. We clearly did not try to characterize this level of sequence identity as similar or dissimilar. However, Warmbrod et al. incorrectly described our writing.
> 
> We did describe ZC45 and ZXC21 as similar when we talked about Figure 1:
> 
> “*ZXC21, which is 97% identical to and shares a very similar profile with ZC45, is not shown*.”
> 
> Clearly, Warmbrod et al. stitched two separate, unrelated descriptions of ours into one sentence and thereby fabricated a statement that we did not actually make.
> 
> Finally, in the legend of Figure 1, we clearly stated that “*similarity plot based on the full-length genome of 2019-nCoV WIV04*.” Anyone with a brain can understand that the genome of 2019-nCoV WIV04 was used as the reference genome here in Figure 1. However, Warmbrod et al., once again, wrongfully accused us of not clarifying what the reference genome was. To say that they acted with a strong bias is clearly a severe understatement of the situation here.


【闫博士】回应：

沃姆布罗德等人再次用同样的伎俩愚弄读者，即歪曲我们的真实叙述。关于新冠和ZC45的相似性，我们实际上说的是：

“*搜索NCBI基因数据库发现，在已知的所有冠状病毒中，有两个关联性的蝙蝠冠状病毒ZC45和ZXC21与新冠有最高的序列一致性（两者都是核苷酸水平89%）*”

我们的描述是准确真实的，我们显然并不试图要定义此水平为相似或不相似。然而，沃姆布罗德等人不正确地转述我们的话。

在我们谈论图表1的时候，我们的确说ZC45和ZXC21是相似的：“*与ZC45有97%一致性且轮廓极为相似的ZXC21此处没有画出*。”

很清楚，沃姆布罗德等人把我们的两个分别的、不相关的叙述拼合进了同一个句子里而伪造了我们没有说过的话。

最后，在图表1的说明中我们清楚地说：“*基于2019-nCoV WIV04全长度基因组的相似度图*”。任何长脑子的人都能理解，是2019-nCoV WIV04的基因组被用在图表1里作为参考基因组。沃姆布罗德等人又一次完全错误地指责我们没把参考基因组搞清楚。在这种情况下说他们明显带有强烈的偏见，已经是很轻的了。


> **Page 4**
> 
> 1. **Similarity of ORF8 between SARS-CoV-2 and ZC45. **Lines 9-14. The authors’ assertion that the similarity between the ORF8 gene in SARS-CoV-2 and ZC45 is unnatural (relative to sequence conservation among coronaviruses) is not supported by the evidence presented. While the sequence of ORF8 varies among coronaviruses, its function is not well characterized. In line 10, the authors report that ORF8 may be involved in SARS-CoV-2’s ability to evade the host immune response (and thus affect pathogenicity). They then suggest that ORF8 is usually dissimilar among different coronavirus strains, based on a paper by Muth et al that studied deletions in ORF8 during the 2003 SARS-CoV-1 epidemic. Muth et al found that a deletion of 29 nucleotides in ORF8 of SARS-CoV-1 attenuated the virus by decreasing the virus’s ability to replicate. A recent paper identified the role of ORF8 in the pathogenesis of SARS-CoV-2 as potentially playing a role in viral maturation and assembly. Importantly, this study on ORF8 was published *after*the emergence of SARS-CoV-2, whose mode of action is still not fully understood; this timeline does not align with Yan and colleagues’ proposed timeline of events. Furthermore, the authors fail to consider the level of similarity in ORF8 between viral variants of the same strain, which could provide better context for the sequence identity between different strains. It is, therefore, inappropriate to suggest that the similarity of SARS-CoV-2 and ZC45 is unusual.


【评议者】

新冠和ZC45在Orf8上的相似度。第9-14行，作者宣称新冠和ZC45在Orf8上的相似度是不自然的（考虑到冠状病毒之间的序列保护），但并没有提供支持证据。当冠状病毒间Orf8的序列不同时，它的功能还没有得到很好地描述。在第10行，作者们报告说，Orf8也许与新冠逃避宿主免疫反应的能力（因而具致病性）有关。他们由此说，Orf8通常在不同冠状病毒菌株之间是不同的。这一结论是基于一份在2003年SARS流行期间由Muth等人研究的有关Orf8缺失的论文。Muth等人发现，SARS1的Orf8有29个核苷酸缺失，因此削弱了病毒，从而降低了病毒的复制能力。一份最近的论文认定了Orf8在新冠发病机理中的角色，即可能在病毒的成熟和组合上起了作用。重要的是，这份Orf8的研究发表在新冠出现之后，这是谁的行为模式还不太清楚。这个时间线和闫及其同事假设的事件时间线并不匹配。更进一步的是，作者未能考虑到，同一菌株的病毒变异间Orf8的相似度水平，这可能会给不同菌株间的序列一致性提供更好的背景。所以，因此表明新冠和ZC45之相似性是不寻常的这一说法是不恰当的。


> Response: Warmbrod et al. once again distorted our descriptions. We have described the high sequence identity (94%) on Orf8 between SARS-CoV-2 and ZC45/ZXC21 as “unusual.” However, at the beginning of the comment above, Warmbrod et al. replaced our word “unusual” with the word “unnatural,” which distorted the meaning of our analysis. The rest of Warmbrod et al.’s comments here are irrelevant. We never said that the function of Orf8 is suggestive of the origin of SARS-CoV-2. Warmbrod et al. literally did not understand our report and made a comment that was neither relevant nor coherent.
> 
> Our point in the report was clear: the 94% sequence identity on Orf8 between SARS-CoV-2 and ZC45/ZXC21 is unusual when no more than 58% sequence identity is exhibited between SARS-CoV-2 and any other naturally occurring coronavirus on Orf8. We continue to stand by this statement.


【闫博士】回应：

沃姆布罗德等人再一次歪曲了我们的叙述。我们已经描述了新冠和ZC45/ZXC21间Orf8上94%的高度序列一致性是“不寻常的”。然而，在上述评议的开头，沃姆布罗德等人把我们“不寻常的”一词替换成了“不自然的”，这就歪曲了我们分析的意思。他们在此处评议的其余部分皆文不对题。我们从来没说过Orf8的功能暗示了新冠的起源。沃姆布罗德等人简直完全不懂我们的报告，并且做出了不相关、不搭界的评议。

我们报告里的观点是清楚的：新冠和ZC45/ZXC21在Orf8上的94%一致性是不寻常的，因为新冠和其他来自于大自然的冠状病毒在Orf8上也只有不超过58%的一致性。我们仍然坚持这一主张。


> 2. Also, lines 11-13: ZC45 and ZXC21 seem to have a 94% identity with ORF8, which is greater than with other circulating coronaviruses (59%), but this is still quite low. ORF8 has been identified as a protein of interest in aiding in virus assembly/packaging. Yan et al argue that SARS-CoV-2 is suspiciously similar to SARS-CoV-1, yet these 2 viruses contain less than 20% similarity in their ORF8 sequences.


【评议者】

同样，第11-13行，ZC45和ZXC21似乎在Orf8上有94%一致性，这比其他圈内的冠状病毒高很多（59%），但这还是很低的。Orf8已被认定是一个有助于病毒组合/整包的蛋白。闫等人争辩说，新冠与SARS1可疑地相似，然而，这两个病毒在Orf8上只有低于20%的一致性。


> Response: We have never said that SARS-CoV-2 is suspiciously similar to SARS-CoV-1 on anything other than the RBM. Here, Warmbrod et al. intentionally carved our words out of our discussion on the RBM and falsely claimed that these words were used for our description of the overall similarity between SARS-CoV-1 and SARS-CoV-2. Such manipulations by Warmbrod et al. distorted our report severely. Their behavior here is simply despicable.


【闫博士】回应：

我们从未说过新冠与SARS1可疑地相似（除了受体绑定域之外），沃姆布罗德等人故意地把我们关于受体绑定域的文字切割出来，然后错误地声称这些文字是被我们用在了新冠与SARS1的整体相似度上。沃姆布罗德等人的这种操作严重歪曲了我们的报告。他们此处的行为简直是卑鄙。

【笔者浅释】注意，这里评议者故意偷换概念。新冠整体上以ZC45为骨架，“移植”借用SARS1的一小段RBM（受体绑定域）是为了利用它来感染人类细胞，SARS1的其他部分与新冠没有关系。所以，即使如评议者说的那样，SARS1和新冠在Orf8上一致性不足20%，这和新冠是以ZC45为骨架，经人为加工而成的这一主题有什么关系？新冠又不是以SARS1为骨架的！评议者完全是文不对题，故弄玄虚，故意搅混水。


> Page 5
> 
> 1. Mischaracterization of sequence homology data. Lines 9-10, referring to Figure 2: The authors present a variety of homology data that are superfluous, internally inconsistent or misinterpreted in the text. For example, the authors state that the E protein, which plays a minimal role in pathogenesis, is highly variable; however, Figure 2 shows a fairly stable amino acid sequence. In lines 4-5, the authors state that SARS-CoV-2’s E gene is highly permissible to mutations because in a 2-month period there have been 4 nonsynonymous mutations. They use this to suggest it is suspicious that early SARS-CoV-2 samples had an identical identity to the purported “backbone” viruses, when SARS-CoV-2 is able to tolerate nonsynonymous mutations to the E gene and, therefore, it would be unlikely for SARS-CoV-2 to have evolved naturally to have 100% sequence identity. However, this analysis does not consider the selection bias in the samples’ sequences and gaps in the existing phylogenetic trees. It is acknowledged in the field that there are gaps in the phylogenetic trees of the coronavirus family, making it difficult to determine accurately the likelihood of similarity between 2 viral variants. Additionally, Figure 2 shows only 1 sequence from an early time point in the pandemic and 4 samples from April. If other samples from February were to be included, then there might not be 100% amino acid sequence identity between SARS-CoV-2 samples and ZC45 and ZXC21. Finally, 2 strains of coronaviruses showing identical sequences in a particular gene could be an example of convergent evolution.


【评议者】

对序列同义数据的错误描述。第9-10行，按照图表2，作者们提供了花哨的几组同义数据，然而这些数据存在内在不一致性或文中有误。例如，作者说，在发病机理中作用最小的E蛋白是高度可变异的，然而图表2显示了相当稳定的氨基酸序列。在4-5行，作者说，新冠的E基因是高度可变异的，因为在两个月里有四处非同义变异。他们用这一点说明，早期新冠样本与假设的骨架病毒的完全一致是可疑的，当新冠能容许E蛋白非同义变异的时候，新冠不可能带着100%（E蛋白）一致性在自然界进化出来。然而，这个分析没考虑样本序列的选择偏好，以及现存系统树的空当。业内公认，在冠状病毒家族的系统树上存在空当，这令精确界定两种病毒的可能相似度变得很困难。另外，图表2只显示了早期大流行的一个序列和4月的四个样本。如果其他2月的样本能被包括进来，也许新冠和ZC45/ZXC21就不是100%（E蛋白）氨基酸一致了。最后，两个冠状病毒菌株显示，某个位置的序列完全一致可以是趋同进化的样例。


> Response: Warmbrod et al. once again distorted our description to make room for inserting criticisms. We have not described the E protein as highly variable or highly permissible to mutations. Instead, we stated that the E protein is tolerant and permissible to mutations even though it is a functionally conserved, structural protein.
> 
> Furthermore, Warmbrod et al. are shocking ignorant in phylogenetic analyses and evolutionary biology. The similarity is high when the sequence identity is 100%, which is true regardless of whether there are gaps (missing species) in the phylogenetic tree. It is basic knowledge that sequence identities/homologies determine phylogenetic relationships, not vice versa. The lack of basic understanding of evolutionary biology here by Warmbrod et al. is astonishing.
> 
> Therefore, importantly, having possible gaps in the phylogenetic trees does not alter the fact that the 100% identity on the E protein between SARS-CoV-2 and ZC45/ZXC21 is highly suspicious.
> 
> Warmbrod et al. also argued that, if more samples from February were to be included, then there might not be 100% amino acid sequence identity between these SARS-CoV-2 samples and ZC45/ZXC21. Such a scenario, however, would further prove our point that the E protein is tolerant and permissible to mutations. An important fact here is that the earliest isolates of SARS-CoV-2 share 100% amino acid identities on the E protein with ZC45/ZXC21. Sequencing data clearly indicated that the selection pressure on the E protein is not strong or biased enough to purge away any amino acid mutations. The 100% identity on the E protein between ZC45/ZXC21 and the earliest SARS-CoV-2 isolates is highly suspicious.
> 
> Finally, Warmbrod et al. commented that convergent evolution could have led to the 100% identity on E between SARS-CoV-2 and ZC45/ZXC21. Although it is theoretically possible, in reality, it is not. SARS-CoV-2 and ZC45/ZXC21 infect different hosts. Therefore, the cellular environment is significantly different for these viruses during their separate routes of evolution, which determines that the selection pressure is not going to drive the E protein into an identical sequence. The existence of an intermediate host would make it even more impossible. Rather, the opposite should be expected – no 100% amino acid identity should be observed here. Again, the 100% identity on the E protein between SARS-CoV-2 and ZC45/ZXC21 is highly suspicious and a clear sign of ZC45/ZXC21 being used as the template for the creation of SARS-CoV-2.


【闫博士】回应：

沃姆布罗德等人又歪曲我们的叙述来给他们塞入批评的空间。我们没说过E蛋白是高度可变或高度容许变异的。相反，我们说，尽管E蛋白是功能保守的结构蛋白，但它宽容并允许变异。

更进一步的是，沃姆布罗德等人在进化生物学和系统进化分析上惊人的无知。当序列一致性是100%时，相似度是真的高，甭管有没有空当（缺少的种类）。这是基本常识，序列一致性决定系统进化关系，反之不成立。沃姆布罗德等人在这里连这种生物进化的基本知识都没有，实在令人吃惊。

所以重要的是，系统树上可能的空当并不改变这一事实，即新冠和ZC45/ZXC21在E蛋白上100%一致是极为可疑的。

沃姆布罗德等人还辩称，如果更多2月份的样本能被包括进来也许新冠和模板ZC45/ZXC21的氨基酸序列（E蛋白）就不是100%一致了。然而这一方案，将更加证明我们的观点，即E蛋白是宽松且容许变异的。在此，一个重要的事实是，最早提取的新冠与ZC45/ZXC21在E蛋白上氨基酸序列100%一致。基因数据清楚说明，E蛋白的选择压力并不强大或偏好到足以排除任何氨基酸变异。尽管理论上可能，但事实上不可能。新冠和ZC45/ZXC21会感染不同的宿主，所以在它们各自的进化进程中，其细胞环境极为不同，这决定了选择压力不会驱使（这两种病毒的）E蛋白变成同一个序列，而中间宿主的存在甚至会让它变得更加不可能。倒是可以预期看到相反的一面，即不会于此观察到100%的氨基酸一致性。再说一遍，新冠和ZC45/ZXC21在E蛋白上的100%一致性是高度可疑的，也是ZC45/ZXC21被用于制造新冠的清楚的标志。


> 2. **Binding with ACE2. **Lines 31-34: In a discussion about whether RaTG13 can bind various ACE2 homologs from different types of horseshoe bats, the authors neglect to point out that the ACE2 homolog of the specific species of horseshoe bat from which RaTG13 was isolated was not included in the cited binding studies. This makes conclusions about whether RaTG13 can bind ACE2 homologues incomplete.


【评议者】

绑定受体。第31-34行，在讨论RaTG13是否能绑定不同种类马蹄蝠的不同的同源受体时，作者忽略不提马蹄蝠（RaTG13从它身上提取）的同源特定物种受体没有被包括在引证的绑定研究中。这使关于RaTG13能否绑定同源受体的结论不完整。


> Response: Warmbrod et al. once again altered the fact here. Our actual description was “*the receptor-binding domain (RBD) of the RaTG13’s Spike protein could not bind ACE2 of two different types of horseshoe bats (they closely relate to the horseshoe bat R. affinis, RaTG13’s alleged natural host)*.” Clearly, we fully acknowledged that the ACE2 of *R. affinis*was not tested. Warmbrod et al. completely ignored this fact and criticized a “mistake” in our report, which we did not actually make.


【闫博士】回应：

沃姆布罗德等人又在此偷换事实。我们说的是“RaTG13刺突的受体绑定域无法绑定两种马蹄蝠（它们与据说是RaTG13自然宿主的马蹄蝠R. affinis是近亲）的受体”。很清楚，我们完全知道R. affinis的受体没有被测试过。沃姆布罗德等人完全无视事实，然后批评我们报告中实际上并未犯下的“错误”。


> 3. **Binding of *Rhinolophus affinis*ACE 2. **Lines 34-36: Research22 has shown that the receptor-binding domain of SARS-CoV-2 binds human, pangolin, and *Rhinolophus macrotis*bat ACE2 receptors optimally, and that the receptor-binding domain of *Rhinolophus affinis*, a type of horseshoe bat, did not bind the ACE2 of orthologous (different) horseshoe bat species’ ACE2. *R affinis*ACE2 has not been well characterized, so it could not be tested. This is interesting work in progress but does not provide substantive conclusions about the provenance of SARS-CoV-2.


【评议者】

R. affinis的受体。第34-36行，研究已经显示，新冠的受体绑定域能最佳绑定人类、穿山甲和大耳菊头蝠的受体。而R. affinis（一种马蹄蝠）的受体结合域，不绑定直系同源的马蹄福（不同）的受体。R. affinis受体还没有得到很好的描绘，所以它无法被测试。这是正在进行的有趣的工作，但不证明关于新冠起源的实质性结论。


> Response: This is an unbelievable comment, which shows that Warmbrod et al.’s knowledge of and understanding of coronavirus biology are extremely superficial.
> 
> Warmbrod et al. stated above that “*the receptor-binding domain of Rhinolophus affinis did not bind the ACE2 of orthologous (different) horseshoe bat species’ ACE2.*” However, the RBD is not from *Rhinolophus affinis*, which is a species of bats. Rather, the RBD is from the RaTG13 virus, which was isolated from *Rhinolophus affinis*. The lack of knowledge by Warmbrod et al. is astonishing, which highlights the fact that Warmbrod et al. are completely unqualified in reviewing our report. In fact, their behaviors here – offering completely biased and mistaken reviews on a global health-related scientific report while totally unqualified in serving as reviewers – are unacceptable and reprehensible.
> 
> Natural evolution ensures that the ACE2 of *Rhinolophus affinis*would be much more homologous to ACE2 of closely related horseshoe bats than to human ACE2. When the ACE2 receptors from two closely related horseshoe bats do not bind RaTG13’s RBD at all, it is not only safe but also reasonable to deduce that the ACE2 receptor from *R. affinis*may not be able to bind RaTG13’s RBD. The inability to recognize or knowingly denial of, this simple logic underscores the lack of qualifications of Warmbrod et al. as unbiased reviewers.


【闫博士】回应：

这是不可信的评议，显示出沃姆布罗德等人在冠状病毒生物学方面的知识和理解是极其肤浅的。

沃姆布罗德等人于上说：“R. affinis（一种马蹄蝠）的受体结合域，不绑定直系同源的马蹄福（不同）的受体”。然而，此受体绑定域并非来自R. affinis（一种蝙蝠），相反，它来自RaTG13病毒，一种从R. affinis提取的病毒。沃姆布罗德等人对此类知识的缺乏是惊人的，这凸显出沃姆布罗德等人作为我们报告的评议者是完全不够格的。事实上，他们这种行为——在作为评议者完全不合格的情况下，就有关全球性健康的报告做出完全错误的和充满偏见的评议——是不可接受和应该被谴责的。

自然演变确保了R. affinis的受体与近亲马蹄蝠的受体的一致性会比与人类受体（的一致性）好得多。当两种近亲马蹄蝠的受体完全不能绑定RaTG13的绑定域时，推论出R. affinis的受体不太可能绑定RaTG13的绑定域是有道理且可靠的。不能认识到这一点，或明知却故意否认这样简单的逻辑，勾勒出沃姆布罗德等人是缺乏素养和充满偏见的评议者。


> 1. **Missing methods section. **The report is missing a methods section, which is typically included in review articles and allows for critical review of the process by which the articles reviewed were chosen. Information should be included about how the alignments were created, sequence quality, and adjustments for sampling bias — all factors that affect the results and conclusions.


【评议者】

方法部分的缺失。这份报告缺少方法的单元，此单元一般都会包括在评议性论文中，并且允许（评议者）对所评议的文章所选择的过程进行批评性审查。关于比对（多序列比对）是怎么做的，序列的质量如何，以及对抽样偏差的调整——所有影响结果和结论的要素的信息应该被包括进来。


> Response: The comment is incorrect and misleading. Although we did not have a separate method section, we have provided sufficient details in figure legends to ensure that every single one of our analyses could be validated by others. Unlike what Warmbrod et al. have criticized, we indeed described how our alignments were done. In the legend of Figure 2, we specified that “*alignments were done using the MultAlin webserver (http://multalin.toulouse.inra.fr/multalin/)*.” We did not list this information again in Figure 4. However, it is the routine in a scientific paper that, when the same method was used for sequence alignment and the details of this method have already been provided in the paper, the same details do not have to be presented in full again.
> 
> All sequences used in our report are published on GenBank, and the quality of these sequences is ensured by the database. Our practice here does not differ from any published work. There is also no issue of sampling bias here. We specified clearly which sequences were used, and our conclusions, which are supported by our alignments using these sequences, remain valid under any combination of sequence sampling and alignment. To prove us wrong here, Warmbrod et al. ought to show which exact sequence is biased, why they could argue so, what an unbiased alignment would look like, and whether or not a different conclusion could be drawn here. They clearly did none of those here.
> 
> Importantly, Warmbrod et al. have no right to define what our report is. Our report is an evidence-based, strictly scientific publication, but not necessarily a review article. Nowhere in the world would they find a scientific review article that is complicated by all the following issues: it concerns a worldwide crisis; it is critical to global health and thus is extremely urgent; it has to deal with a series of large-scale, organized scientific fraud; it faces the resistance from a regime as powerful as the Chinese Communist Party.
> 
> In the end, the most important aspect of an article is its scientific quality and robustness, not the format or how the method information within is grouped. Consistent with this notion, in our report, we have presented substantial scientific data and analyses in a logical and coherent manner. We have also specified unique features of the SARS-CoV-2 genome (restrictions sites, rare codons, evolutionary abnormalities, etc), which strongly support our conclusion that SARS-CoV-2 is of a lab origin. We also cited over one hundred references in a strictly scientific manner, which showed who had the necessary materials and information for the lab creation of SARS-CoV-2 and who has been engaged in relevant gain-of-function research.


【闫博士】回应：

这个评议是不正确且具误导性的。尽管我们没有一个单独的方法单元，我们已经在配图说明里提供了大量细节来确保每个单独的分析对别人来说都是有效的。并不像沃姆布罗德等人批评的那样，我们的确叙述了我们的比对是怎么做的。在图表2的说明里，我们详细说明“比对是用MultAlin webserver做的（附网址）”。我们没有在图表4里重复这一信息。然而，这是科学论文的惯例，当比对序列采用的方法相同时，同样的细节不需要完整重复地提供。

我们报告中用到的所有序列是基因库发表的，这些序列的质量是由数据库保证的。我们的做法和任何发表的作品没有两样。这里也不存在抽样偏差调整。我们清楚说明了用了哪些序列，以及我们的结论——那是由我们用的这些序列的比对支持的，在任何序列采样和比对的组合下都是有效的。要证明我们这里错了，沃姆布罗德等人应该确切出示哪条序列有偏差，他们为什么这样主张，是什么样的比对偏差，以及是否会因此得出不同的结论。显然，这些他们都没做。重要的是，沃姆布罗德等人无权规定我们的报告该是什么样的。我们的报告是基于证据的，严格的科学出版物，而不必是一篇评议文章。他们不会在世上任何地方找到一篇评议文章会包含如下复杂要素：它涉及一场世界性的危机；它对全球健康至关重要，因此极为紧迫；它必须对付一系列大规模、有组织的科学欺诈；它面临着来自中国共产党这样强大政权的阻力。

最后，这篇文章最重要的是它的科学品质和坚实性，而非形式或组织信息的方式。与此相一致，我们一贯以合乎逻辑的方式提供了大量的科学数据和分析。我们也说清楚了新冠的独特基因特征（限制性位点、稀有密码子、进化的异常等等），这强烈支持了我们的结论，即新冠是实验室起源。我们也以严格科学的方式引证了超过一百份参考资料，说明了谁拥有实验室制造新冠的必须材料和资料，以及谁卷入了相关的功能获得性研究。


> 1. **On the variability of Spike sequences. **Lines 1-13: There are various judgments about the similarity of SARS-CoV-2 sequences to other related viruses (ZC45 and ZXC21), but no inclusion of contrasting evidence. For example, S2 is not highly variable among coronaviruses, but S1 is only a 69% match, making the claims that ZC45 was used as a template not credible. Convergent evolution, seen in several other viruses, including SARS-CoV-1, often as a virulence factor, should be considered by the authors.


【评议者】

一种刺突序列变异。第1-13行，对于新冠序列和其他相关病毒（ZC45/ZXC21）的一致性有各种评判，但没有包含对比性证据。例如，在冠状病毒里S2不是高度可变异的，但是S1只有69%的符合度，这使ZC45被用作模板的说法不可信。如几个其他病毒（包括SARS1）那样，趋同进化经常是一个恶意因素，应该被作者们考虑进去。


> Response: Warmbrod et al. once again showed their lack of quality as reviewers. If they had read the whole report and understood the contents at a basal level, they would have realized that, although ZC45/ZXC21 was used as a template, many changes must have been introduced into S1. Particularly, we have elaborated in great detail how the RBM region of S1 was swapped. This manipulation would contribute significantly to a low sequence identity on S1 between ZC45/ZXC21 and SARS-CoV-2. Therefore, the low identity on S1 is not a piece of evidence against the notion that ZC45/ZXC21 was used as a template. Rather it strongly supports our overall conclusion that the lab creation of SARS-CoV-2 had involved genetic engineering and manipulation, not merely serial passages based on a naturally occurring coronavirus, such as ZC45/ZXC21.
> 
> We have detailed in section 1.2 of our report how convergent evolution could not lead to the natural occurrence of SARS-CoV-2. Apparently, it is not that we did not consider this aspect; it is Warmbrod et al. intentionally neglecting this part of our work in making their comment here. If any of our analyses concerning convergent evolution is incorrect or questionable, Warmbrod et al. should specify it and offer their own analyses against it. A blunt ignorance and/or denial of our analyses is a behavior that is very inappropriate for reviewers.


【闫博士】回应：

沃姆布罗德等人再次显示他们作为评议者的缺乏素养。如果他们读过全篇报告并在基本水平上理解了内容的话，他们就会认识到，尽管ZC45/ZX21被用作了模板，S1中还是被引入了许多变异。特别是，我们已经详细说明了，S1的绑定域是被置换了的。这种改造极大地造成新冠和ZC45/ZXC21在S1上的一致性较低。所以，S1上的低一致性并非是一个不利于证明ZC45/ZXC21被用作模板的证据。相反，它强烈支持了我们关于新冠是实验室制造的整体结论。这种制造包括基因工程和基因改造，而不仅仅是基于自然冠状病毒（例如ZC45/ZXC21）的连续传代。

我们已经在报告的1.2中详细说了，为什么趋同进化不可能导致新冠的自然出现。显然，不是我们没考虑到这个方面，是沃姆布罗德等人故意地忽视了我们报告中的这个部分，以便能做出评议。如果我们任何关于趋同进化的分析是不正确的，或有问题的，沃姆布罗德等人应该把它说清楚，并提供他们自己的相反分析。这种对我们的分析生硬的忽略或拒绝承认，对于评议者来说是非常不恰当的行为。

【笔者浅释】第一篇报告1.2中对趋同进化做了相当长篇幅地分析，正常人绝对不可能漏看。简单回顾如下：

新冠病毒绑定人类细胞受体的关键点是刺突蛋白中S1里面一段名叫受体结合基序（RBM）的70个核苷酸长度的片段。ZC45/ZXC21（以下简称ZC45）是新冠爆发前与新冠最接近的冠状病毒（RaTG13、穿山甲病毒等一系列中共伪造的“纸上病毒”上根本不存在，忽略不计），如果新冠不能从ZC45进化而来，自然更不可能从别的病毒上进化了。虽然，ZC45在其他部分和新冠有95%一致性，在S1却只有69%一致性，因此，要通过自然环境下的趋同演变而得到新冠，需要很长很长很长的时间，所以这是不可能的。如果是靠基因重组（好比器官移植），从别的病毒那里得来，那么将产生两个问题：一、假设这个移植发生在很久以前，那么这个移植了新RBM的新ZC45病毒必须要广泛适应新的宿主，并继续发生趋同进化，使它的RBM变成现在的样子，但这个过程必然导致它整体上发生相当数量的随机变异，因而整体面目大变。实际情况却是：ZC45和新冠虽然在S1上差异较大，除此以外的其他部分一致性却高达95%，因此久远前发生的基因重组这个可能性被排除。第二个问题，如果是不久前发生的基因重组，那么它要满足四个条件：A）两种病毒必须是相似的；B）两种病毒同处在同一动物的同一个细胞里；C）重组后的病毒没有被宿主细胞弄死，也没有把宿主弄死，否则就没机会传播出去； D）重组后的病毒在宿主体内变得稳定并可以在同物种里传播。由此可见，这个可供两种病毒同时相处的动物宿主不可能是蝙蝠，因为蝙蝠细胞受体和人类细胞受体同源度太低，无法令RBM进化成能绝佳地适应人类的；这动物宿主也不可能是人类，因为ZC45没有能力进入人类细胞并和某种感染人类的冠状病毒共处。那么，只剩下一种可能性，就是两种病毒同处在某种中间宿主细胞里——这个中间宿主细胞的受体必须与人类细胞受体同源，否则重组后的新病毒的RBM还是无法进化成具有新冠这种能绑定人类细胞受体的能力。目前，中共找的几种中间宿主全部失败，而最新计算机模拟研究排查了几乎所有物种后表明，几乎没有任何动物适合做中间宿主。如果再把被用作“移植”的来源是SARS1这个历史上只出现过一次的罕见病毒这个因素考虑进去，这种“移植”置换简直是天方夜谭。连石正丽也不得不公开承认同时狡辩说，“新冠病毒很狡猾”，中间宿主可能永远找不到。

因此，新冠不可能是ZC45在自然界靠趋同进化而来，其他相似度不如ZC45的冠状病毒就更没有可能了。以上仅仅是简单回顾，详情请查阅闫博士第一篇报告原文。令人惊奇的是，闫博士报告里关于趋同进化有这么长篇幅地分析论述，评议者竟然能做到视而不见，这绝不是人类能做到的。

![]()![](https://gnews.org/wp-content/uploads/2021/04/4_April.jpg)

编辑/校对/发稿：Irene木木

**更多资讯，更多关注**

[**纽约香草山农场GTV****–****香草山之声**](https://gtv.org/user/5ffbdcd7f579a75e0bd123e6)

**[纽约香草山农场GTV-MOS TALK香草山访谈](https://gtv.org/getter/601aeffdf5b9e26ca9d7ad10)**

**[纽约香草山农场Twitter（中文）](https://twitter.com/HIMALAYA_MOS)**

**[纽约香草山农场Twitter（英文](https://twitter.com/MosHimalaya)**[**）**](https://twitter.com/MosHimalaya)

[**纽约香草山农场 You****Tube**](https://www.youtube.com/channel/UCSLHrqs6Pil7V-_jOuZVVgg)

![]()![](https://gnews.org/wp-content/uploads/2021/01/GNEW-GTV-MOS-LOGO-2-2-1.jpg)





0
